Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repeat-dose antimicrobial photodynamic therapy for chronic leg ulcers
2008-005079-90Phase 2Terminated
- Sponsor
- Photopharmica
- Start
- Jan 2009
- Modality
- Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in leg ulcer comparing PPA904 antimicrobial photodynamic therapy with Placebo control (2 arms). Primary endpoints: Reduction in bacterial content of chronic leg ulcers and Improvement in healing of chronic leg ulcers. Started Jan 2009; status: terminated.
02
Drugs
PPA-904
03
Conditions
leg ulcer
Beyond the preview
Go deeper on 2008-005079-90.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005079-90.